ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 131 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $70,000 | +11.1% | 6,144 | +101.6% | 0.00% | – |
Q1 2017 | $63,000 | +200.0% | 3,048 | +204.8% | 0.00% | – |
Q4 2016 | $21,000 | -44.7% | 1,000 | -13.0% | 0.00% | – |
Q3 2016 | $38,000 | +850.0% | 1,150 | +666.7% | 0.00% | – |
Q2 2016 | $4,000 | 0.0% | 150 | 0.0% | 0.00% | – |
Q1 2016 | $4,000 | -80.0% | 150 | -74.9% | 0.00% | – |
Q3 2015 | $20,000 | +17.6% | 598 | 0.0% | 0.00% | – |
Q1 2015 | $17,000 | 0.0% | 598 | 0.0% | 0.00% | – |
Q4 2014 | $17,000 | +112.5% | 598 | 0.0% | 0.00% | – |
Q3 2014 | $8,000 | – | 598 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |